CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture
The BIO CELLX provides cell biologist with pre-validated protocols to eliminate barriers for automating 3D cell-based assays targeting cancer research and drug discovery.Today CELLINK, A BICO Company, launched the BIO CELLX a novel system that automates 3D cell culture workflows by leveraging pre validated protocols. The BIO CELLX builds upon CELLINK’s impressive bioprinting portfolio utilizing proven technologies like the patented Clean Chamber combined with a unique new method for effortless mixing of hydrogels and cells, high precision dispensing and automatic nozzle priming to create a